STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3389 by analyst upside · 2026-06-27
ESTA
Establishment Labs Holdings Inc.
Healthcare · Market Cap $3B · P/E 0x
ANALYST PRICE TARGET
+3.2%
implied upside to consensus target
Current Price $88.38
Consensus Target $91.22
Bull Target $100.0
Bear Target $76.0
Analysts Covering 9
ANALYST CONSENSUS — BUY
Strong Buy
2
Buy
6
Hold
1
Sell
0
52-Week Low $33.35
52-Week High $90.5
YTD Return +28.4%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) N/A
Forward P/E 1178.4x
EPS (TTM) $-1.47
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $230M
Profit Margin -19.1%
52-WEEK RANGE
52-Week Low $33.35
52-Week High $90.5
Current Price $88.38
Bear Target $76.0
Bull Target $100.0
● Now $88.38 ● Target $91.22
TRADING DATA
Avg Volume 508K
YTD Return +28.4%
Analyst Count 9
Consensus Buy
Upside to Target +3.2%
Last Updated 2026-06-27

ANALYST SUMMARY

Establishment Labs Holdings Inc. (ESTA) is currently trading at $88.38 with a Wall Street consensus price target of $91.22, implying potential upside of 3.2% over the next 12 months. 9 analysts currently cover ESTA, with a consensus rating of Buy — 89% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $100.0, while the most cautious has a target of $76.0.

ESTA operates in the Healthcare sector with a market capitalisation of $3B. The stock is up 28.4% year-to-date and is currently trading near the upper end of its 52-week range of $33.35 – $90.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ESTA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BTIG — Reiterated
Buy → Buy 2026-05-07 38% win rate (8 calls)
BTIG reit
Buy → Buy 2026-04-29 38% win rate (8 calls)
Citigroup — Reiterated
Neutral → Neutral 2026-03-11 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2026-02-26 Building track record
Stephens & Co. — Reiterated
Overweight → Overweight 2026-02-25 Building track record
Mizuho — Reiterated
Outperform → Outperform 2026-02-25 Building track record
Needham — Reiterated
Buy → Buy 2026-02-24 20% win rate (5 calls)
BTIG — Reiterated
Buy → Buy 2026-02-24 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →